Complex Insight - Understanding our world
12.2K views | +0 today
Follow
Complex Insight  - Understanding our world
A few things the Symbol Research team are reading.  Complex Insight is curated by Phillip Trotter (www.linkedin.com/in/phillip-trotter) from Symbol Research
Your new post is loading...
Your new post is loading...
Scooped by Phillip Trotter
Scoop.it!

‘It’s a real-life Hunger Games’: a lifesaving drug costs $2m, but not every child can get it | Pharmaceuticals industry | The Guardian

‘It’s a real-life Hunger Games’: a lifesaving drug costs $2m, but not every child can get it | Pharmaceuticals industry | The Guardian | Complex Insight  - Understanding our world | Scoop.it
Zolgensma is a revolutionary gene therapy that can stop a deadly childhood condition called SMA in its tracks.It’s also one of the most expensive drugs in the world...
No comment yet.
Scooped by Phillip Trotter
Scoop.it!

Physiologically Based Pharmacokinetics (PBPK) | Absorption | Formulation | Pharmacodynamics | Drug Drug Interaction | Population PK

Physiologically Based Pharmacokinetics (PBPK) | Absorption | Formulation | Pharmacodynamics | Drug Drug Interaction | Population PK | Complex Insight  - Understanding our world | Scoop.it

The Pharmaceutical industry continues to adopt simulation technologies for drug discovery and development. This week Simulations Plus, Inc., a provider of simulation and modeling software announced it had signed a collaboration agreement with a major pharmaceutical company to add a transdermal and subcutaneous dosing model within its GastroPlus simulation software program. GastroPlus™ is a mechanistic, physiologically-based simulation program that predicts the absorption, pharmacokinetics, and pharmacodynamics for drugs given through oral, intravenous, ocular or pulmonary routes.The funded collaboration enable Simulations Plus to extend the competitive advantage of GastroPlus without the need for Simulations Plus to fund the development directly.

 

 

 

 

No comment yet.
Scooped by Phillip Trotter
Scoop.it!

Roche looks to personal future

Roche looks to personal future | Complex Insight  - Understanding our world | Scoop.it
Swiss pharmaceutical company Roche, with over SFr9.5 billion ($10.35 billion) in profits for 2011, is looking to secure its future and betting on personalised medicine in the process.
No comment yet.
Scooped by Phillip Trotter
Scoop.it!

Conquering HIV’s capsid | July 31, 2017 Issue - Vol. 95 Issue 31 | Chemical & Engineering News

Conquering HIV’s capsid | July 31, 2017 Issue - Vol. 95 Issue 31 | Chemical & Engineering News | Complex Insight  - Understanding our world | Scoop.it
First potential new novel  treatment for HIV in 10 years leverages the geometry of the HIV Capsid
No comment yet.
Scooped by Phillip Trotter
Scoop.it!

Pharma land

Pharma land | Complex Insight  - Understanding our world | Scoop.it

The Swiss chemical and pharmaceutical industry – accounts for over 4 % of Gross Domestic Product and is the second most important industry, behind the engineering industry for the swiss economy. Good overview of the companies pharma industry.

No comment yet.
Scooped by Phillip Trotter
Scoop.it!

BioPortfolio - the Biotechnology, Pharmaceutical, Life-Science and Healthcare Portal

BioPortfolio - the Biotechnology, Pharmaceutical, Life-Science and Healthcare Portal | Complex Insight  - Understanding our world | Scoop.it
BioPortfolio.com - the life science and healthcare portal BioPortfolio brings our visitors continuously updated biotechnology, pharmaceutical and healthcare n...
No comment yet.